Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008

The companies — Rosetta Genomics, MDRNA, and Tekmira Pharmaceuticals — have all seen their shares more than double since Dec. 31, significantly outperforming the Nasdaq Biotechnology Index.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.